Renal cell carcinoma (RCC) with angioleiomyoma-like stroma appears to be molecularly distinct from clear cell RCC; however, its relationship to clear cell papillary RCC remains debated. Recent studies have found that similar tumors sometimes occur in patients with tuberous sclerosis complex (TSC), of which one study found unexpectedly negative succinate dehydrogenase (SDH) B immunostaining. We evaluated immunohistochemistry for SDHB in 12 apparently sporadic RCCs with angioleiomyoma-like stroma and correlated with clinical information for stigmata of TSC. Tumors were compared to a group of 16 clear cell papillary RCCs and 6 unclassified tumors with prominent stroma.
SDHB protein, often requiring high magnification and better appreciated with increased antibody concentration. Detailed history information was available for 9/12 patients with smooth muscle-rich tumors, revealing no stigmata of undiagnosed TSC. Electron microscopy performed on 1 of these tumors revealed mitochondria to be very sparse, potentially accounting for the weak immunohistochemical labeling for SDHB protein.
Weak SDHB immunostaining may represent another shared feature of RCC with angioleiomyoma-like stroma and clear cell papillary RCC, likely due to sparse mitochondria, strengthening the possible relationship of these entities. Although smooth muscle-rich tumors have been recently reported in patients with TSC, absence of staining in tumors with this pattern may not be specific for TSC. In tumors with pale or clear cytoplasm, immunohistochemical staining for SDHB should be interpreted with caution as evidence of abnormality in the SDH pathway.
Introduction
Renal cell carcinomas with angioleiomyoma-like stroma(1, 2) and likely related entities renal cell carcinoma with smooth muscle stroma (3, 4) and renal angiomyoadenomatous tumor, (5, 6 ) are thought to be immunohistochemically and molecularly distinct from clear cell renal cell carcinoma.(2, 7) However, it remains debated whether these tumors should be regarded as variants of clear cell papillary renal cell carcinoma,(8-10) due to the shared features of cytokeratin 7 and high molecular weight keratin immunohistochemical labeling and lack of reactivity for alpha-methyl-acyl-coAracemase (AMACR), combined with absence of other defining genetic alterations.(2, 7)
Interestingly, two recent reports have noted a tendency to encounter a similar morphology in patients with tuberous sclerosis complex,(11, 12) of which one study found the tumors to be unexpectedly negative for succinate dehydrogenase B (SDHB) immunohistochemical staining.(12) We therefore sought to assess SDHB immunohistochemical staining in a cohort of apparently sporadic tumors with smooth muscle stroma, to determine whether negative staining is consistently associated with this morphology, or with tuberous sclerosis-associated tumors.
Materials and Methods
A cohort of 12 renal cell carcinomas with angioleiomyoma-like stroma from 11 patients were selected for analysis, of which 10 tumors from 9 patients were previously were also tested at the increased concentration to confirm that their abnormal negative staining was retained under these conditions. Detailed clinical, imaging, and family history was available for 9/11 of the patients with renal cell carcinoma with angioleiomyoma-like stroma to evaluate for stigmata of undiagnosed tuberous sclerosis. For electron microscopy, formalin-fixed but unprocessed tissue was retrieved from the remaining gross specimen after initial histologic examination in 1 renal cell carcinoma with angioleiomyoma-like stroma. This was subsequently fixed in glutaraldehyde, and processed according to routine protocol for clinical transmission electron microscopy in 
Results
In renal cell carcinoma with angioleiomyoma-like stroma (Figure 1) One of the two studies of renal cancers in tuberous sclerosis patients found that the papillary renal cell carcinomas with fibromuscular stroma were abnormally negative for SDHB immunohistochemical staining,(12) an unexpected finding, since SDHB loss is intuitive in the setting of germline SDH subunit gene alterations (27) (28) (29) but not in the setting of TSC1 and TSC2 gene mutations. Therefore, we sought to assess whether this abnormal lack of SDHB staining in renal cell tumors is specific for the angioleiomyomalike stroma morphology, associated with tuberous sclerosis patients specifically, or occurs for other reasons. We found that although staining is typically very weak, at least focal cytoplasmic granular labeling can be appreciated in almost all of these tumors, especially  SDHB staining is weak but focally present in renal tumors with smooth muscle stroma  Clear cell papillary renal cell carcinoma exhibits a similar staining pattern  These findings are likely the result of sparse mitochondria rather than protein defect  Further study is needed to determine if this is tumor is related to tuberous sclerosis
